Folic acid supplementation enhances arsenic methylation: results from a folic acid and creatine supplementation randomized controlled trial in Bangladesh.

Background Arsenic exposure through drinking water persists in many regions. Inorganic As (InAs) is methylated to monomethyl-arsenical species (MMAs) and dimethyl-arsenical species (DMAs), facilitating urinary excretion. Arsenic methylation is dependent on one-carbon metabolism, which is influenced by nutritional factors such as folate and creatine. Objective This study investigated the effects of folic acid (FA) and/or creatine supplementation on the proportion of As metabolites in urine. Design In a 24-wk randomized, double-blinded, placebo-controlled trial, 622 participants were assigned to receive FA (400 or 800 μg per day), 3 g creatine per day, 400 μg FA + 3 g creatine per day, or placebo. The majority of participants were folate sufficient; all received As-removal water filters. From wk 12-24, half of the participants receiving FA received placebo. Results Among groups receiving FA, the mean decrease in ln(%InAs) and %MMAs and increase in %DMAs exceeded those of the placebo group at wk 6 and 12 (P < 0.05). In the creatine group, the mean decrease in %MMAs exceeded that of the placebo group at wk 6 and 12 (P < 0.05); creatine supplementation did not affect change in %InAs or %DMAs. The decrease in %MMAs at wk 6 and 12 was larger in the 800 µg FA than in the 400 µg FA group (P = 0.034). There were no differences in treatment effects between the 400 µg FA and creatine + FA groups. Data suggest a rebound in As metabolite proportions after FA cessation; at wk 24, log(%InAs) and %DMAs were not significantly different than baseline levels among participants who discontinued FA supplementation. Conclusions The results of this study confirm that FA supplementation rapidly and significantly increases methylation of InAs to DMAs. Further research is needed to understand the strong cross-sectional associations between urinary creatinine and As methylation in previous studies. This trial was registered at https://clinicaltrials.gov as NCT01050556.

[1]  X. Le,et al.  Comparative cytotoxicity of fourteen trivalent and pentavalent arsenic species determined using real-time cell sensing. , 2016, Journal of environmental sciences.

[2]  J. Graziano,et al.  Provision of well-water treatment units to 600 households in Bangladesh: A longitudinal analysis of urinary arsenic indicates fading utility. , 2016, The Science of the total environment.

[3]  Michael Reed,et al.  Mathematical analysis of the regulation of competing methyltransferases , 2015, BMC Systems Biology.

[4]  F. Parvez,et al.  Low-Dose Creatine Supplementation Lowers Plasma Guanidinoacetate, but Not Plasma Homocysteine, in a Double-Blind, Randomized, Placebo-Controlled Trial. , 2015, The Journal of nutrition.

[5]  F. Parvez,et al.  Folic Acid and Creatine as Therapeutic Approaches to Lower Blood Arsenic: A Randomized Controlled Trial , 2015, Environmental health perspectives.

[6]  E. V. de Paula,et al.  Folate, Vitamin B12 and Homocysteine status in the post-folic acid fortification era in different subgroups of the Brazilian population attended to at a public health care center , 2015, Nutrition Journal.

[7]  V. Slavkovich,et al.  Creatinine, Arsenic Metabolism, and Renal Function in an Arsenic-Exposed Population in Bangladesh , 2014, PloS one.

[8]  Guifan Sun,et al.  Differences of Urinary Arsenic Metabolites and Methylation Capacity between Individuals with and without Skin Lesions in Inner Mongolia, Northern China , 2014, International journal of environmental research and public health.

[9]  L. Moore,et al.  Increased Lung and Bladder Cancer Incidence in Adults after In Utero and Early-Life Arsenic Exposure , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[10]  J. Baron,et al.  Arsenic metabolism efficiency has a causal role in arsenic toxicity: Mendelian randomization and gene-environment interaction. , 2013, International journal of epidemiology.

[11]  Rebecca S. Williamson,et al.  Near-elimination of folate-deficiency anemia by mandatory folic acid fortification in older US adults: Reasons for Geographic and Racial Differences in Stroke study 2003-2007. , 2013, The American journal of clinical nutrition.

[12]  L. Moore,et al.  Drinking Water Arsenic in Northern Chile: High Cancer Risks 40 Years after Exposure Cessation , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[13]  Habibul Ahsan,et al.  The Broad Scope of Health Effects from Chronic Arsenic Exposure: Update on a Worldwide Public Health Problem , 2013, Environmental health perspectives.

[14]  M. Gamble,et al.  Nutritional Manipulation of One-Carbon Metabolism: Effects on Arsenic Methylation and Toxicity , 2012, Journal of toxicology.

[15]  Jane Liaw,et al.  Creatinine, Diet, Micronutrients, and Arsenic Methylation in West Bengal, India , 2011, Environmental health perspectives.

[16]  M. Brosnan,et al.  The metabolic burden of creatine synthesis , 2011, Amino Acids.

[17]  P. Ueland.  Choline and betaine in health and disease , 2011, Journal of Inherited Metabolic Disease.

[18]  C. Skibola,et al.  Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. , 2010, Toxicology and Applied Pharmacology.

[19]  C. Wagner,et al.  Glycine N-Methyltransferase and Regulation of S-Adenosylmethionine Levels* , 2009, The Journal of Biological Chemistry.

[20]  V. Slavkovich,et al.  Folate, Cobalamin, Cysteine, Homocysteine, and Arsenic Metabolism among Children in Bangladesh , 2009, Environmental health perspectives.

[21]  V. Slavkovich,et al.  Folate Deficiency, Hyperhomocysteinemia, Low Urinary Creatinine, and Hypomethylation of Leukocyte DNA Are Risk Factors for Arsenic-Induced Skin Lesions , 2008, Environmental health perspectives.

[22]  A. Ronnenberg,et al.  Can folate intake reduce arsenic toxicity? , 2008, Nutrition reviews.

[23]  F. Parvez,et al.  Folic acid supplementation lowers blood arsenic. , 2007, The American journal of clinical nutrition.

[24]  F. Jasmine,et al.  Arsenic Metabolism, Genetic Susceptibility, and Risk of Premalignant Skin Lesions in Bangladesh , 2007, Cancer Epidemiology Biomarkers & Prevention.

[25]  S. Waters,et al.  Arsenic (+3 Oxidation State) Methyltransferase and the Methylation of Arsenicals , 2007, Experimental biology and medicine.

[26]  F. Parvez,et al.  Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. , 2006, The American journal of clinical nutrition.

[27]  M. Vahter,et al.  Arsenic exposure in pregnancy: a population-based study in Matlab, Bangladesh. , 2006, Journal of health, population, and nutrition.

[28]  F. Parvez,et al.  Health Effects of Arsenic Longitudinal Study (HEALS): Description of a multidisciplinary epidemiologic investigation , 2006, Journal of Exposure Science and Environmental Epidemiology.

[29]  F. Parvez,et al.  Folate, Homocysteine, and Arsenic Metabolism in Arsenic-Exposed Individuals in Bangladesh , 2005, Environmental health perspectives.

[30]  Rebecca C. Miller,et al.  Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. , 2004, Clinical chemistry.

[31]  E. Silbergeld,et al.  Variability in human metabolism of arsenic. , 2003, Environmental research.

[32]  C. J. Chen,et al.  Arsenic methylation capacity and skin cancer. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  D. E. Carter,et al.  Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. , 2000, Toxicology and applied pharmacology.

[34]  B. Fowler,et al.  Arsenic: health effects, mechanisms of actions, and research issues. , 1999, Environmental health perspectives.

[35]  M. Vahter.  Methylation of Inorganic Arsenic in Different Mammalian Species and Population Groups , 1999, Science progress.

[36]  D. A. Jencks,et al.  Allosteric inhibition of methylenetetrahydrofolate reductase by adenosylmethionine. Effects of adenosylmethionine and NADPH on the equilibrium between active and inactive forms of the enzyme and on the kinetics of approach to equilibrium. , 1987, The Journal of biological chemistry.

[37]  R. Cook,et al.  Inhibition of glycine N-methyltransferase activity by folate derivatives: implications for regulation of methyl group metabolism. , 1985, Biochemical and biophysical research communications.

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[39]  F. Challenger.  Biological methylation. , 1951, Advances in enzymology and related subjects of biochemistry.